В здравом уме и твердой памяти. Программа профилактики болезни Альцгеймера

Dijkstra, K., et al. “Body posture facilitates retrieval of autobiographical memories.” Cognition 102 (2007): 139–49.

Ybarra, O., et al. “Mental exercising through simple socializing: social interaction promotes general cognitive functioning.” Pers Soc Psychol Bull 34 (2008): 248–59.

Глава 10

Sarkisian, C. A., et al. “Pilot test of an attribution retraining intervention to raise walking levels in sedentary older adults.” J Am Geriatr Soc 55 (2007): 1842–46.

Pope, S. K., et al. “Will a healthy lifestyle help prevent Alzheimer’s disease?” Ann Rev Public Health 42 (2003): 111–32.

Yang, K., et al. “Outcomes of health care providers’ recommendations for healthy lifestyle among U.S. adults with prediabetes.” Metab Syndr Relat Disord 9 (2011): 231-37.

Adams, C. E., and M. R. Leary. “Promoting self-compassionate attitudes toward eating among restrictive and guilty eaters.” J Soc Clin Psych 26 (2007): 1120–44.

Sol, B. G., et al. “The effect of self-efficacy on cardiovascular lifestyle.” Eur J Cardiovasc Nurs 29 Jul 2010.

http://www.sciencedirect.com/science/article/pii/S1474515110000812.

Yon, B. A., et al. “Personal digital assistants are comparable to traditional diaries for dietary self-monitoring during a weight loss program.”J Behav Med 30 (2007): 165–75.

Burke, L. E., et al. “Self-monitoring in weight loss: a systematic review of the literature.” J Am Diet Assoc 111 (2011): 92–102.

Дополнительные источники

Honea, R. A., et al. “Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease.” Neurology 74 (2010): 113–20.

Mosconi, L., et al. “Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.” Neurology 72 (2009): 513–20.

Frisardi, V., et al. “Aluminum in the diet and Alzheimer’s disease: from current epidemiology to possible disease-modifying treatment.” J Alzheimers Dis. 20 (2010): 17–30.

Rondeau, V., et al. “Aluminum and silica in drinking water and the risk of Alzheimer’s disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort.” Am J Epidemiol 169 (2009): 489–96.

Whitmer, R. A., et al. “Timing of hormone therapy and dementia: The critical window theory revisited.” Ann Neurol 69 (2011): 163–39.

Petersen, R. C., et al. “Vitamin E and donepezil for the treatment of mild cognitive impairment.” N Engl J Med 352 (2005): 2379–88.

Silverman, D.H.S., et al. “Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects.” Alzheimer’s Association International Conference on Alzheimer’s Disease, 2008.

Cataldo, J. K., et al. “Cigarette smoking is a risk factor for Alzheimer’s Disease: an analysis controlling for tobacco industry affiliation.” J Alzheimers Dis 19 (2010): 465–80.

Volkow, N. D., et al. “Effects of cell phone radiofrequency signal exposure on brain glucose metabolism.” JAMA 305 (2011): 808–13.

Arendash, G. W., T. Mori, et al. “Electromagnetic field treatment protects against and reverses cognitive impairment in Alzheimer’s disease mice.” J Alzheim Dis 19 (2010): 191–210.

Kamer, A. R., et al. “Inflammation and Alzheimer’s disease: Possible role of periodontal diseases.” Alzheim Dement 4 (2008): 242–50.

Bates, M. N. “Mercury amalgam dental fillings: an epidemiologic assessment.” Int J Hyg Environ Health 209 (2006): 309–16.

Yücel, M., et al. “Regional brain abnormalities associated with long-term heavy cannabis use.” Arch Gen Psychiatry 65 (2008): 694–701.

Scholes, K. E., and M. T. Martin-Iverson. “Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia.” Psychol Med 40 (2010): 1635–46.

Morgan, C. J., et al. “Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study.” Br J Psychiatry 197 (2010): 285–90.

Lifshitz, V., et al. “Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.” Neurobiol Aging 1 Mar 2011. http://www.sciencedirect.com/science/article/pii/S019745801100008X.

Bettermann, K., et al. “Statins, risk of dementia, and cognitive function: Secondary analysis of the Ginkgo Evaluation of Memory Study.” J Stroke Cerebrovasc Dis 12 Jan 2011. http://www.sciencedirect. com/science/article/pii/S1052305710002533

McGuinness B, et al. Statins for the treatment of dementia. Cochrane Database Syst Rev 14 Aug 2010 (8): CD007514.

Evans, M. A., and B. A. Golomb. “Statin-associated adverse cognitive effects: survey results from 171 patients.” Pharmacotherapy 29 (2009): 800–11.